Media

03 March 2026

Advancing Huntington’s Disease Research: Harness at the 21st Annual CHDI Foundation Therapeutics Conference

Read more

28 February 2026

Rare Disease Day

Read more

26 February 2026

EQT Group Life Sciences’ BioCapital Europe in Amsterdam

Read more

16 February 2026

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

Read more

11 February 2026

Visit from Charles Sabine, OBE

Read more

05 February 2026

CHDI Foundation's Annual Huntington’s Disease Therapeutics Conference in Palm Springs

Read more

07 January 2026

44th Annual J.P. Morgan Healthcare Conference in San Francisco

Read more

21 November 2025

London at the NextGen Omics, Spatial and Data Symposium 2025

Read more

14 November 2025

Jeffries Global Healthcare Conference in London

Read more

11 November 2025

BIO Europe 2025

Read more

21 October 2025

ELRIG Drug Discovery 2025 Conference

Read more

14 October 2025

Harness attends HD Clinical Research Congress

Read more

Our programmes

Huntington's Disease

ALS and Alzheimer's

Parkinson’s Disease

Our news

May 2024

Harness attend Target ALS Annual Meeting

Read more

April 2024

Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair

Read more

February 2024

Harness attend the 19th Annual Huntington's Disease Therapeutics Conference

Read more

December 2023

Our new website is LIVE!

Read more